Companies

Celgene

NASDAQ: CELG
$108.24
▲ $0.00 (+0.00%) today
Markets closed · 1:23am ET

CELG Coverage

Page 3
8:30am ET
Health and Healthcare

Short Sellers Back Off Major Biotechs

The January 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.

Chris Lange
8:50am ET
Health and Healthcare

Bristol-Myers, Celgene to Tie a $74 Billion Knot

Bristol-Myers has announced a definitive agreement to acquire rival Celgene in a cash and stock deal worth $74 billion. Celgene shareholders are scheduled to receive a 54% premium to Wednesday night's closing…

Paul Ausick
8:20am ET
Health and Healthcare

Short Sellers Back Off Major Biotechs

The September 28 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.

Chris Lange
8:20am ET
Health and Healthcare

Short Sellers Up the Ante in Major Biotechs

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The August 31 short interest data have been compared with the previous report, and short interest in most…

Chris Lange